- Home
- Publications
- Publication Search
- Publication Details
Title
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
Authors
Keywords
BNT162b2 mRNA vaccine, COVID-19, SARS-CoV-2, Saliva, IgA
Journal
EBioMedicine
Volume 75, Issue -, Pages 103788
Publisher
Elsevier BV
Online
2021-12-24
DOI
10.1016/j.ebiom.2021.103788
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Florian Krammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy
- (2021) Claudio Azzolini et al. JAMA Ophthalmology
- The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data
- (2021) Gabriel Chodick et al. CLINICAL INFECTIOUS DISEASES
- Early antibody response in healthcare professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)
- (2021) Julien Favresse et al. CLINICAL MICROBIOLOGY AND INFECTION
- Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection
- (2021) Janeri Fröberg et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Assessment of salivary antibody response to BNT162b2 mRNA COVID‐19 vaccination
- (2021) Ivana Lapić et al. JOURNAL OF MEDICAL VIROLOGY
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- SARS-CoV-2 infection of the oral cavity and saliva
- (2021) Ni Huang et al. NATURE MEDICINE
- SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
- (2021) Jocelyn Keehner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delivery Routes for COVID-19 Vaccines
- (2021) Jang Hyun Park et al. Vaccines
- Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
- (2021) Vivek P. Chavda et al. DRUG DISCOVERY TODAY
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
- (2021) Irene Soffritti et al. Frontiers in Microbiology
- Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines
- (2021) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection
- (2021) Henry Daniell et al. MOLECULAR THERAPY
- Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
- (2021) Dennis Lapuente et al. Nature Communications
- Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study
- (2021) Ariel Israel et al. BMJ-British Medical Journal
- The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
- (2021) Renee W. Y. Chan et al. Frontiers in Immunology
- Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA
- (2021) Eva Piano Mortari et al. Cells
- Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
- (2021) Kadhim Hayawi et al. Vaccines
- SARS CoV-2 Delta variant exhibits enhanced infectivity and a minor decrease in neutralization sensitivity to convalescent or post-vaccination sera
- (2021) Alona Kuzmina et al. iScience
- Clinical And Analytical Performance Of An Automated Serological Test That Identifies S1/S2 Neutralizing IgG In COVID-19 Patients Semiquantitatively.
- (2020) Fabrizio Bonelli et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’
- (2020) Enrico Lavezzo et al. NATURE
- Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
- (2020) Rajat Mudgal et al. Human Vaccines & Immunotherapeutics
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
- (2020) Michael W. Russell et al. Frontiers in Immunology
- What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
- (2020) Susanne H Hodgson et al. LANCET INFECTIOUS DISEASES
- OptimalCutpoints: AnRPackage for Selecting Optimal Cutpoints in Diagnostic Tests
- (2015) Mónica López-Ratón et al. Journal of Statistical Software
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started